Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Amgen Inc (AMGN)

Amgen Inc (AMGN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 138,777,776
  • Shares Outstanding, K 574,554
  • Annual Sales, $ 25,424 M
  • Annual Income, $ 7,264 M
  • 60-Month Beta 0.71
  • Price/Sales 5.48
  • Price/Cash Flow 10.54
  • Price/Book 14.93
Trade AMGN with:

Options Overview

Details
  • Implied Volatility 18.39%
  • Historical Volatility 27.22%
  • IV Percentile 2%
  • IV Rank 4.57%
  • IV High 42.23% on 10/28/20
  • IV Low 17.25% on 06/17/21
  • Put/Call Vol Ratio 0.28
  • Today's Volume 14,376
  • Volume Avg (30-Day) 9,927
  • Put/Call OI Ratio 0.67
  • Today's Open Interest 144,188
  • Open Int (30-Day) 133,687

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 20 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/21
See More
  • Average Estimate 4.13
  • Number of Estimates 10
  • High Estimate 4.49
  • Low Estimate 3.90
  • Prior Year 4.25
  • Growth Rate Est. (year over year) -2.82%

Price Performance

See More
Period Period Low Period High Performance
1-Month
227.10 +3.03%
on 08/04/21
250.39 -6.55%
on 07/20/21
-14.71 (-5.91%)
since 07/02/21
3-Month
227.10 +3.03%
on 08/04/21
258.81 -9.59%
on 05/10/21
-15.36 (-6.16%)
since 05/05/21
52-Week
210.28 +11.28%
on 10/29/20
276.69 -15.43%
on 01/28/21
-7.48 (-3.10%)
since 08/05/20

Most Recent Stories

More News
Stock Market News for Aug 5, 2021

The Dow and the S&P 500 closed in the red on Wednesday weighed by a lower-than-expected private-sector jobs report and Fed's Vice Chairman Richard Clarida's comment on higher interest rates in 2023 given...

AMD : 112.35 (-5.41%)
CVX : 101.23 (+0.93%)
CAT : 207.19 (+1.31%)
APA : 18.06 (+1.75%)
AMGN : 233.99 (+2.49%)
MRNA : 416.26 (-0.67%)
GM : 54.44 (+3.26%)
SGEN : 162.20 (-0.62%)
WBA : 46.93 (+0.84%)
TEAM : 342.43 (+0.58%)
DOCU : 305.61 (+1.21%)
Amgen (AMGN) Q2 Earnings Top, COVID-Led Sales Woes to Linger

Amgen (AMGN) beats Q2 estimates for both earnings and sales. It expects the pandemic to continue to hurt sales growth in the second half of 2021.

RHHBY : 49.3900 (+1.42%)
BMY : 68.42 (-0.10%)
LLY : 264.19 (+0.66%)
AMGN : 233.99 (+2.49%)
Stock Market News for Aug 4, 2021

Benchmarks closed in the positive territory on Tuesday, as investors ignored the rise in new cases of the delta variant, and instead focused more on the upbeat second-quarter earnings results.

BA : 229.94 (+1.46%)
AMZN : 3,375.99 (+0.63%)
AAPL : 147.06 (+0.07%)
AMD : 112.35 (-5.41%)
MSFT : 289.52 (+1.05%)
V : 240.21 (+1.50%)
IBM : 142.77 (+0.01%)
COP : 55.95 (+1.86%)
AMGN : 233.99 (+2.49%)
MMM : 197.80 (+0.14%)
MCD : 236.42 (+0.68%)
MU : 81.49 (-0.60%)
DIS : 176.71 (+2.39%)
MRNA : 416.26 (-0.67%)
NTES : 87.71 (-5.71%)
UAA : 24.81 (+4.20%)
TCOM : 24.73 (+2.27%)
S&P Reaches New Record as Stocks Bounce Back

S&P Reaches New Record as Stocks Bounce Back

BABA : 199.28 (-0.71%)
AMGN : 233.99 (+2.49%)
BP : 25.34 (+1.12%)
COP : 55.95 (+1.86%)
ATVI : 80.32 (-1.47%)
AVT : 41.15 (-0.46%)
SNDR : 21.47 (+0.23%)
VOLT : 5.46 (+2.82%)
AMD : 112.35 (-5.41%)
CDNS : 151.76 (+0.45%)
QCOM : 146.83 (-0.94%)
UVXY : 26.82 (-3.63%)
SPXS : 21.73 (-1.90%)
TEX : 49.43 (+1.35%)
ASIX : 35.37 (+1.03%)
ALTO : 5.23 (+7.61%)
Amgen (AMGN) Surpasses Q2 Earnings and Revenue Estimates

Amgen (AMGN) delivered earnings and revenue surprises of 6.05% and 1.48%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

AMGN : 233.99 (+2.49%)
Amgen: Q2 Earnings Snapshot

THOUSAND OAKS, Calif. (AP) _ Amgen Inc. (AMGN) on Tuesday reported second-quarter earnings of $464 million.

AMGN : 233.99 (+2.49%)
Better-Than-Expected Earnings Push Pre-Markets Higher

Better-Than-Expected Earnings Push Pre-Markets Higher

ATVI : 80.32 (-1.47%)
BP : 25.34 (+1.12%)
COP : 55.95 (+1.86%)
AMGN : 233.99 (+2.49%)
PRU : 102.08 (+2.18%)
MTCH : 146.42 (-2.76%)
UAA : 24.81 (+4.20%)
Stock Futures Indicate Higher Opening on Strong Q2 Earnings

Stock futures rise in pre-market trade on impressive second-quarter earnings results.

ATVI : 80.32 (-1.47%)
BP : 25.34 (+1.12%)
COP : 55.95 (+1.86%)
AMGN : 233.99 (+2.49%)
PRU : 102.08 (+2.18%)
MTCH : 146.42 (-2.76%)
UAA : 24.81 (+4.20%)
What's in the Cards for Amarin (AMRN) This Earnings Season?

Amarin's (AMRN) second-quarter results are likely to reflect recovery in Vascepa sales amid potential recovery in COVID-19 related disruptions.

SNY : 50.56 (+1.36%)
DVAX : 10.33 (+4.55%)
AMGN : 233.99 (+2.49%)
AMRN : 4.86 (+9.46%)
American Kidney Fund Launches Kidney Kitchen Pro™ to Expand Patient Nutrition Resources for Renal Professionals

--News Direct--

AMGN : 233.99 (+2.49%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Strengthening short term outlook on maintaining the current direction.

See More Share

Business Summary

Amgen Inc. discovers, develops and delivers innovative human therapeutics. A biotechnology pioneer, Amgen was one of the first companies to realize the new science's promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice...

See More

Key Turning Points

3rd Resistance Point 241.98
2nd Resistance Point 238.01
1st Resistance Point 236.00
Last Price 233.99
1st Support Level 230.02
2nd Support Level 226.05
3rd Support Level 224.04

See More

52-Week High 276.69
Fibonacci 61.8% 251.32
Fibonacci 50% 243.49
Fibonacci 38.2% 235.65
Last Price 233.99
52-Week Low 210.28

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar